Mirae Asset Global Investments Co., Ltd. Madrigal Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 70,179 shares of MDGL stock, worth $23.6 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
70,179
Previous 76,822
8.65%
Holding current value
$23.6 Million
Previous $16.3 Million
32.83%
% of portfolio
0.09%
Previous 0.07%
Shares
9 transactions
Others Institutions Holding MDGL
# of Institutions
335Shares Held
22.3MCall Options Held
960KPut Options Held
940K-
Janus Henderson Group PLC London, X02.21MShares$741 Million0.36% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$686 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$681 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$669 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$663 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.74B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...